Hans Hoffmann
About
Hans Hoffmann is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery.
According to data from OpenAlex, Hans Hoffmann has authored 146 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Pulmonary and Respiratory Medicine, 47 papers in Oncology and 24 papers in Surgery. Recurrent topics in Hans Hoffmann's work include Lung Cancer Diagnosis and Treatment (58 papers), Lung Cancer Treatments and Mutations (47 papers) and Pleural and Pulmonary Diseases (22 papers). Hans Hoffmann is often cited by papers focused on Lung Cancer Diagnosis and Treatment (58 papers), Lung Cancer Treatments and Mutations (47 papers) and Pleural and Pulmonary Diseases (22 papers). Hans Hoffmann collaborates with scholars based in Germany, United States and United Kingdom. Hans Hoffmann's co-authors include Hendrik Dienemann, Joachim Pfannschmidt, Thomas Muley, Arne Warth, Philipp A. Schnabel, Felix Herth, Michael Meister, Peter Schirmacher, Michael Thomas and Wilko Weichert and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.
In The Last Decade
Hans Hoffmann
133 papers receiving 5.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Hans Hoffmann Germany | 40 | 3.5k | 2.0k | 905 | 729 | 647 | 146 | 5.3k | ||
| Marco Alloisio Italy | 36 | 3.0k 0.8× | 1.7k 0.9× | 843 0.9× | 652 0.9× | 884 1.4× | 157 | 4.6k | ||
| Michael Lanuti United States | 41 | 3.3k 0.9× | 1.6k 0.8× | 1.3k 1.4× | 745 1.0× | 677 1.0× | 187 | 5.4k | ||
| Masahiko Higashiyama Japan | 45 | 3.6k 1.0× | 2.1k 1.1× | 986 1.1× | 948 1.3× | 1.5k 2.3× | 202 | 6.2k | ||
| Salma K. Jabbour United States | 33 | 2.1k 0.6× | 2.1k 1.1× | 853 0.9× | 979 1.3× | 503 0.8× | 244 | 4.3k | ||
| Wallace Akerley United States | 36 | 3.1k 0.9× | 2.7k 1.4× | 515 0.6× | 361 0.5× | 1.1k 1.7× | 156 | 5.2k | ||
| Masato Hareyama Japan | 36 | 3.3k 1.0× | 1.6k 0.8× | 1.7k 1.9× | 1.4k 1.9× | 836 1.3× | 178 | 6.2k | ||
| Daniel J. Boffa United States | 33 | 4.1k 1.2× | 2.2k 1.1× | 1.4k 1.6× | 858 1.2× | 624 1.0× | 166 | 6.3k | ||
| Deborah Kuk United States | 41 | 1.9k 0.5× | 2.8k 1.4× | 871 1.0× | 348 0.5× | 619 1.0× | 78 | 4.6k | ||
| Ashley E. Winkler United States | 10 | 2.5k 0.7× | 3.9k 2.0× | 1.4k 1.6× | 751 1.0× | 1.1k 1.8× | 12 | 7.3k | ||
| Norihiko Ikeda Japan | 43 | 4.5k 1.3× | 1.8k 0.9× | 1.2k 1.3× | 1.1k 1.5× | 740 1.1× | 346 | 6.3k |
Countries citing papers authored by Hans Hoffmann
Since
Specialization
Citations
This map shows the geographic impact of Hans Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Hoffmann more than expected).
Fields of papers citing papers by Hans Hoffmann
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Hans Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Hoffmann. The network helps show where Hans Hoffmann may publish in the future.
Co-authorship network of co-authors of Hans Hoffmann
This figure shows the co-authorship network connecting the top 25 collaborators of Hans Hoffmann. A scholar is included among the top collaborators of Hans Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Hoffmann. Hans Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Safi, Seyer, Dorothea Weber, Rouven Behnisch, et al.. (2024). Peri- and postoperative morbidity and mortality in older patients with non-small cell lung cancer: a matched-pair study. World Journal of Surgical Oncology. 22(1). 213–213.
2.
Detterbeck, Frank C., Marcin Ostrowski, Hans Hoffmann, et al.. (2024). The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the Classification of Residual Tumor After Resection for the Forthcoming (Ninth) Edition of the TNM Classification of Lung Cancer. Journal of Thoracic Oncology. 19(7). 1052–1072.
3.
Vogel‐Claussen, Jens, Torsten Blum, Stefan Andreas, et al.. (2023). Positionspapier zur Implementierung eines nationalen organisierten Programms in Deutschland zur Früherkennung von Lungenkrebs in Risikopopulationen mittels Low-dose-CT-Screening inklusive Management von abklärungsbedürftigen Screeningbefunden. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 196(2). 134–153.
4.
Hoffmann, Hans, Rudolf Kaaks, Stefan Andreas, et al.. (2023). Positionspapier zur Implementierung eines nationalen organisierten Programms in Deutschland zur Früherkennung von Lungenkrebs in Risikopopulationen mittels Low-Dose-CT-Screening inklusive Management von abklärungsbedürftigen Screening-Befunden. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 149(1). 96–115.
5.
Reyes, Carmen Mota, Fabian Stögbauer, Henrik Einwächter, et al.. (2023). Carcinoid syndrome caused by a pulmonary carcinoid mimics intestinal manifestations of ulcerative colitis: A case report. World Journal of Gastroenterology. 29(33). 5014–5019.
6.
Blum, Torsten, Jens Vogel‐Claussen, Stefan Andreas, et al.. (2023). Positionspapier zur Implementierung eines nationalen organisierten Programms in Deutschland zur Früherkennung von Lungenkrebs in Risikopopulationen mittels Low-dose-CT-Screening inklusive Management von abklärungsbedürftigen Screeningbefunden. Pneumologie. 78(1). 15–34.
7.
Eichhorn, Florian, Laura V. Klotz, Mark Kriegsmann, et al.. (2021). Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experience. Lung Cancer. 153. 150–157.
8.
Yamauchi, Yoshikane, Seyer Safi, C Blattner, et al.. (2018). Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non–Small Cell Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 198(6). 777–787.
9.
Kowalski, Christoph, Ullrich Graeven, Christof von Kalle, et al.. (2017). Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society. BMC Cancer. 17(1). 850–850.
10.
Marek, Lindsay A., Trista K. Hinz, Anne von Mäßenhausen, et al.. (2014). Nonamplified FGFR1 Is a Growth Driver in Malignant Pleural Mesothelioma. Molecular Cancer Research. 12(10). 1460–1469.
11.
Gompelmann, Daniela, Felix Herth, Claus Peter Heußel, et al.. (2014). Pneumothorax following valve treatment. European Respiratory Journal. 44(Suppl 58). P3702–P3702.
12.
Herth, Felix, Daniela Gompelmann, Hans Hoffmann, et al.. (2014). Bronchoscopic trans-parenchymal nodule access (BTPNA) – A new real-time image-guided approach to accessing solitary pulmonary nodules (SPNs) - First in human data. European Respiratory Journal. 44(Suppl 58). P692–P692.
13.
Pass, Harvey I., Dorothy J. Giroux, Catherine Kennedy, et al.. (2014). Supplementary Prognostic Variables for Pleural Mesothelioma: A Report from the IASLC Staging Committee. Journal of Thoracic Oncology. 9(6). 856–864.
14.
Warth, Arne, Thomas Muley, Michael Meister, et al.. (2012). The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival. Journal of Clinical Oncology. 30(13). 1438–1446.
15.
Reinmuth, Niels, Thomas Muley, Hans Hoffmann, et al.. (2012). Characteristics and outcome of patients with second primary lung cancer. European Respiratory Journal. 42(6). 1668–1676.
16.
Warth, Arne, Stephan Macher‐Goeppinger, Thomas Muley, et al.. (2011). Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy. European Respiratory Journal. 39(6). 1437–1442.
17.
Herpel, Esther, Thomas Muley, Thomas Schneider, et al.. (2010). A Pragmatic Approach to the Diagnosis of Nodal Micrometastases in Early Stage Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 5(8). 1206–1212.
18.
Pfannschmidt, Joachim, et al.. (2010). Thoracic Metastasectomy for Nonseminomatous Germ Cell Tumors. Journal of Thoracic Oncology. 5(6). S182–S186.
19.
Singer, Stephan, Mona Malz, Esther Herpel, et al.. (2009). Coordinated Expression of Stathmin Family Members by Far Upstream Sequence Element-Binding Protein-1 Increases Motility in Non–Small Cell Lung Cancer. Cancer Research. 69(6). 2234–2243.
20.
Sakamaki, Fumio, Hans Hoffmann, Christian Müller, et al.. (1997). Reduced Lipid Peroxidation and Ischemia-Reperfusion Injury after Lung Transplantation Using Low-Potassium Dextran Solution for Lung Preservation. American Journal of Respiratory and Critical Care Medicine. 156(4). 1073–1081.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Marco Alloisio Breakdown of academic impact, for papers by Michael Lanuti Breakdown of academic impact, for papers by Masahiko Higashiyama Breakdown of academic impact, for papers by Salma K. Jabbour Breakdown of academic impact, for papers by Wallace Akerley Breakdown of academic impact, for papers by Masato Hareyama Breakdown of academic impact, for papers by Daniel J. Boffa Breakdown of academic impact, for papers by Deborah Kuk Breakdown of academic impact, for papers by Ashley E. Winkler Breakdown of academic impact, for papers by Norihiko Ikeda